Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.JCI Insight|February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIVAne Ogbe, Matthew Pace, Mustapha Bittaye, et al.Pageof 4